Navigation Links
Business Opportunities in Spain's Fast-Growing Biotechnology Industry
Date:7/9/2009

MADRID, July 9 /PRNewswire/ --

- INVEST IN SPAIN would like to invite you to take part in an online seminar entitled "Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector", in which business opportunities will be presented for foreign companies in the sector in Spain. Experts will respond to the questions of participants live.

- The seminar will be held on the 14th of July (12:00pm - 1:30pm Eastern Day Time or 6:00pm - 7:30pm Central European Time (GMT+1 in Spain)

- In order to attend the seminar, you have to first register for free using the following link: http://www.xtalks.com/events/xto341spain3/reg1.html

The biotechnology sector is one of the most dynamic in Spain. It has maintained an annual growth rate for turnover and job creation of 30% according to data from ASEBIO, the Spanish Association of Bio-companies. Spain attracts international projects and financing in biotechnology because it has a solid scientific base, highly qualified workforce, integrated health system, state-of-the-art infrastructures for innovation and major governmental backing. A fast-growing industry in a country with an extraordinary quality of life.

Business opportunities in Spain over the coming years will be linked to fields such as personalized medicine and advanced therapies, where interest is increasing in molecular diagnoses and related products.

In order to analyze opportunities in this field, the following people will participate in the online seminar: Jose Navas, Director of the Carlos III Health Institute, renowned for research into Cellular Therapy and Regenerative Medicine, and Eduardo Bravo, CEO of Cellerix, a company success story for foreign investment being as it is a Spanish company renowned internationally and with the participation of a range of foreign investors.

Enrique Vazquez Tatay, CEO of Neocodex, will also participate. Neocodex is a representative company in Spanish biotechnology development, and an example of the advanced technology and research capital available in Spain. Barbara Lopez, Head of Investor Services at INVEST IN SPAIN and Jorge Arenas Vidal, Director of Bioserentia, will make a general presentation of the sector. The seminar is open to questions from participants, will be held in English and will last approximately one and a half hours.

    For further information:http://www.investinspain.org

    Communication Office of Invest in Spain
    Cristina Exposito Peinado
    cexposito@investinspain.org
    Ana Garcia Camarillo
    agarcia@investinspain.org
    +34-91-503-5835



'/>"/>
SOURCE Invest in Spain
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China Clean Energy Provides Business Update
2. Encorium Group Updates Expected Timeframe with Respect to the Sale of its U.S. Business
3. SenesTech Announces New Vice President of Business Development
4. Gerresheimer Sells Technical Plastics Business
5. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
6. NeoStem Featured in Business Week; Promising Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article
7. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
8. CoreRx, Inc. Announces Plans for Expansions to Meet the Needs of Growing Pharmaceutical Formulation Development Business
9. Next Stage Solutions Announces Three New Financial Services For Emerging Business
10. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
11. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):